PolyNovo Limited (PNV.AX)
ASX · AUD · Healthcare · Medical Devices
A$0.87 (+2.96%) as of
Key statistics
- Market cap
- 601.03M
- P/E (TTM)
- 87.00
- Forward P/E
- 31.95
- EPS (TTM)
- 0.0100
- Dividend yield
- 0.00%
- 52-week range
- 0.8100 – 1.4200
- Beta
- 1.35
- Revenue (TTM)
- 149.85M
- Profit margin
- 4.90%
- Analyst target
- A$1.25
- Volume
- 1.17M
About PolyNovo Limited
PolyNovo Limited designs, manufactures, and sells biodegradable medical devices in Australia, New Zealand, the United States, the United Kingdom, Ireland, Singapore, India, Hong Kong, and China. The company offers NovoSorb Biodegradable Temporising Matrix, a dermal matrix for the regeneration of the dermis when lost through extensive surgery, trauma, or burn; NovoSorb MTX for burns, chronic, trauma, and surgical wounds; and hernia repair, plastics and reconstructive device products. The company was formerly known as Calzada Limited and changed its name to PolyNovo Limited in November 2014. PolyNovo Limited was incorporated in 1998 and is headquartered in Port Melbourne, Australia.
- Sector
- Healthcare
- Industry
- Medical Devices
- Headquarters
- Port Melbourne, VIC, Australia
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.